Inspira Technologies Oxy BHN (IINN) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Inspira Technologies OXY B.H.N. Ltd. has partnered with Glo-Med Networks Inc. to establish a distribution facility in Florida for its INSPIRA ART100 device, cleared for Cardiopulmonary Bypass procedures by the FDA. This move is set to strengthen Inspira’s presence in the U.S. market, aiming to tap into a potential $19 billion market opportunity by enhancing operational efficiency and customer support. The facility will also serve as a hub for future product commercialization, supported by a partnership with Med-Stat Consulting Services.
For further insights into IINN stock, check out TipRanks’ Stock Analysis page.
